The stock faces imminent delisting risk. The hearing request deadline is May 29, 2026 — any delay or negative news from the Panel will likely trigger a sharp sell-off. The convertible note's $6.00 conversion price is far above the current market price (implied by $6M market cap), so near-term dilution is minimal, but the note's secured status and default interest provisions give the holder significant leverage. Traders should monitor for the hearing outcome and any subsequent equity or reverse-split announcements.
Price Chart
Executive Summary
DNA X, Inc. (SONM) disclosed a Nasdaq delisting determination due to a stockholders' deficit of $983,000, violating the $2.5M minimum equity requirement. Concurrently, the company raised $1.8M in new cash via a secured convertible note (total principal $3.05M) from its existing controlling shareholder, who also agreed to terminate a put option that could have forced a reverse acquisition. The delisting risk dominates the filing, as the capital raise is a distressed lifeline from a related party, not an arm's-length vote of confidence.
Key Financial Metrics
Key Facts
- Nasdaq delisting determination received May 22, 2026; trading suspension scheduled for June 2, 2026 unless hearing is requested by May 29, 2026.
- Company reported stockholders' deficit of $983,000 as of March 31, 2026, violating Nasdaq's $2.5M minimum equity requirement.
- Company issued a $3,052,787.68 secured convertible promissory note to DNA Holdings Venture, Inc., its controlling shareholder, for $1.8M cash plus conversion of a prior $1.2M bridge note.
- The note matures December 31, 2026, bears 10% interest (20% upon default), and is convertible at $6.00/share subject to stockholder approval.
- The note is secured by a first-priority lien on the membership interests of the company's wholly owned subsidiary, DNA X, LLC.
- The put option in the prior Membership Interest Purchase Agreement was terminated as part of the transaction.
- Market cap is approximately $6M; the $1.8M cash infusion represents ~30% of market cap.
Financial Impact
The $1.8M cash infusion provides near-term liquidity but is dwarfed by the existential risk of Nasdaq delisting. The company's $983K stockholders' deficit indicates negative equity.
Risk Factors
- Nasdaq delisting would severely reduce liquidity and institutional ownership, likely causing a material price decline.
- The company has negative stockholders' equity and may require additional dilutive financing.
- The secured note gives the holder a priority claim on the subsidiary's assets, potentially impairing other stakeholders.
- The company may need to execute a reverse stock split to regain compliance, which often depresses stock price.
- The note's 20% default interest rate and aggressive conversion terms (80% of market price upon default) create a strong incentive for the holder to trigger default if the stock declines.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-025433 |
| Exhibit: ex10-2.htm | 0001493152-26-025433 |
| Exhibit: ex10-3.htm | 0001493152-26-025433 |
| Document: form8-k.htm | 0001493152-26-025433 |
| Document: 0001493152-26-025433-index-headers.html | 0001493152-26-025433 |
| Document: 0001493152-26-025433-index.html | 0001493152-26-025433 |
| Document: 0001493152-26-025433.txt | 0001493152-26-025433 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 8w ago | 8-K | $3.53 $4.57 | ▲ +29.50% | ▲ +29.19% | $2.96 (−16.03%) |
Aug 27, 2026 8w ago | 8-K | $3.27 $4.06 | ▲ +24.16% | ▲ +24.26% | $2.96 (−9.48%) |
Aug 19, 2026 9w ago | Press Release | $3.44 $2.96 | ▲ +13.95% | ▲ +13.95% | $2.96 (+13.95%) |
Jul 2, 2026 16w ago | 8-K | $3.75 $3.25 | ▲ +13.33% | ▲ +12.92% | $2.96 (+21.07%) |
Jun 12, 2026 19w ago | EFFECT | $4.74 $4.05 | ▲ +14.56% | ▲ +16.34% | $2.96 (+37.55%) |
Jun 4, 2026 20w ago | 8-K | $4.75 $4.21 | ▼ −11.37% | ▼ −13.23% | $2.96 (−37.68%) |
May 27, 2026 21w ago | 8-K | $4.24 $5.70 | ▼ −34.43% | ▼ −37.58% | $2.96 (+30.19%) |
Apr 30, 2026 25w ago | 8-K / 10-K/A | $4.89 $4.73 | ▲ +3.27% | ▲ +8.56% | $2.96 (+39.47%) |
Apr 14, 2026 27w ago | 8-K | $3.15 $5.10 | ▲ +61.90% | ▲ +55.86% | $2.96 (−6.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers